{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:51:19Z","timestamp":1790769079358,"version":"4.1.0"},"reference-count":119,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T00:00:00Z","timestamp":1175040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirality"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>U.S. Food and Drug Administration issues certain guidelines for marketing of optically active drugs as some enantiomers racemize into human body, leading to the generation of other antipodes, which may be toxic or ballast to the human beings. Moreover, racemization reduces the administrated dosage concentration as optically active enantiomer converted into its inactive counter part. Therefore, the study of racemization of such type of drugs is an important and urgent need of today. This article describes in vitro and in vivo racemization of optically active drugs. The racemization process of various optically active drugs has been discussed considering the effect of different variables i.e. pH, temperature, concentration of the drug, ionic concentration, etc. Attempts have also been made to discuss the mechanisms of racemization. Besides, efforts have been made to suggest the safe dosages of such type of drugs too. Chirality, 2007. \u00a9 2007 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/chir.20397","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T20:18:44Z","timestamp":1175113124000},"page":"453-463","source":"Crossref","is-referenced-by-count":105,"title":["Role of racemization in optically active drugs development"],"prefix":"10.1002","volume":"19","author":[{"given":"Imran","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Y.","family":"Aboul\u2010Enein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavtosh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,3,28]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"541","volume-title":"Hand book of TLC","author":"G\u00fcnther K","year":"1991"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1201\/9780203911112"},{"key":"e_1_2_1_4_2","first-page":"123","article-title":"Mechanism of the teratogenic action of thalidomide","volume":"21","author":"Sergio F","year":"1967","journal-title":"Acta Vitaminologica et Enzymologica"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00570141"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.10221"},{"key":"e_1_2_1_7_2","first-page":"695","article-title":"Presystemic and systemic chiral inversion of R\u2010(\u2212)\u2010fenoprofen in the rat","volume":"258","author":"Berry BW","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1996)8:3<258::AID-CHIR5>3.0.CO;2-D"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-02503-9"},{"key":"e_1_2_1_10_2","first-page":"259","article-title":"Asymmetric synthesis\u2014Meeting the challenge","volume":"25","author":"Davies SG","year":"1989","journal-title":"Chem Br"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(03)00402-4"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2002.tb02759.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/009127009803801203"},{"key":"e_1_2_1_14_2","first-page":"254","article-title":"Difference between the effects of (\u2212) clausenamide and (+) clausenamide on the synaptic transmission in the dentate gyrus of anesthetized rats","volume":"33","author":"Liu S","year":"1998","journal-title":"Yao Xue Xue Bao"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(79)90060-X"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1997)9:1<29::AID-CHIR6>3.0.CO;2-B"},{"key":"e_1_2_1_17_2","first-page":"107","article-title":"Vigabatrin plasma enantiomer concentrations and clinical effects","volume":"29","author":"Sheean G","year":"1992","journal-title":"Clin Exp Neurol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1999)11:2<103::AID-CHIR4>3.0.CO;2-1"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050509"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.11.028"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90647-3"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530070603"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389200043335360"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600840903"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.37.2786"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1039\/an9800501068"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)82091-9"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)00585-4"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.51.492"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00235a027"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90762-9"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90588-V"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530020202"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb1978.4.1"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.10229"},{"key":"e_1_2_1_36_2","first-page":"45","volume-title":"The impact of stereochemistry on drug development and use","author":"Mason JP","year":"1997"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.3.344"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0090-9556(24)15164-1","article-title":"Assessment of the metabolic chiral inversion of D\u2010leucine in rat by gas chromatography\u2010mass spectrometry combined a stable isotop dilution analysis","volume":"28","author":"Hasegawa H","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.10005"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1996)8:2<214::AID-CHIR7>3.0.CO;2-I"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1999)11:3<179::AID-CHIR2>3.0.CO;2-G"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530070510"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530060416"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530060304"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530050209"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600781002"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530040708"},{"key":"e_1_2_1_48_2","first-page":"485","article-title":"Mechanism of racemization of 3\u2010hydroxy\u20101,4\u2010benzodiazepines in alcoholic solvents","volume":"3","author":"Yang SK","year":"1998","journal-title":"Enantiomer"},{"key":"e_1_2_1_49_2","first-page":"181","article-title":"Racemizzazione in ambiente acido dei cloruri del tipo RCH(R')COCl","volume":"32","author":"Sulla TV","year":"1962","journal-title":"Ric Sci"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/1520-636X(2000)12:10<697::AID-CHIR1>3.0.CO;2-L"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00037a023"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1998)10:4<307::AID-CHIR4>3.0.CO;2-4"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.20148"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530070413"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530050518"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530050109"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2004.07.011"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(93)80157-V"},{"key":"e_1_2_1_59_2","unstructured":"KnocheB BlaschkeG.Racemization of thalidomide in vitro. Presented at the 4th International symposium on chiral discrimination September 19\u201322 1993 Montreal Canada. Abstract 144."},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(89)90155-0"},{"key":"e_1_2_1_61_2","first-page":"1073","article-title":"Synthesis, central nervous system activity and teratogenicity of a homothalidomide","volume":"40","author":"Eger K","year":"1990","journal-title":"Arzneim\u2010Forsch (Drug Res)"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600630514"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530060507"},{"key":"e_1_2_1_64_2","first-page":"405","article-title":"Mechanistic studies on the metabolic chiral inversion of R\u2010ibuprofen in the rat","volume":"19","author":"Sanins SM","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1976.tb04144.x"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600650222"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02694.x"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4838(91)90164-U"},{"key":"e_1_2_1_69_2","volume-title":"The impact of stereochemistry on drug development and use","author":"Aboul\u2010Enein HY","year":"1997"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(74)90231-9"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.51.4.576"},{"key":"e_1_2_1_72_2","first-page":"119","article-title":"Stereoselective disposition\u2010basis for variability in response to NSAIDs","volume":"17","author":"Williams KM","year":"1985","journal-title":"Agents Actions"},{"key":"e_1_2_1_73_2","first-page":"322","article-title":"Metabolic inversion of (R)\u2010ibuprofen. Epimerization and hydrolysis of ibuprofenyl\u2010coenzyme A","volume":"20","author":"Tracy TS","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_1_74_2","first-page":"527","article-title":"Studies on the metabolism and chiral inversion of ibuprofen in isolated rat hepatocytes","volume":"18","author":"Sanins SM","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90184-7"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199834020-00002"},{"key":"e_1_2_1_77_2","first-page":"195","article-title":"Ibuprofen stereochemistry: double\u2010the\u2010trouble?","volume":"4","author":"Tan SC","year":"1999","journal-title":"Enantiomer"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03342662"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(92)90393-4"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90537-0"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530070707"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016046810103"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2885.2000.00280.x"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600740122"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015867513045"},{"key":"e_1_2_1_86_2","first-page":"356","article-title":"Stereoselective inversion of (R)\u2010(\u2212) benoxaprofen to the (S)\u2010(+) enantiomer in humans","volume":"7","author":"Bopp RJ","year":"1979","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03189461"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1999)11:10<781::AID-CHIR7>3.0.CO;2-9"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1983.tb02874.x"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(90)90095-J"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(01)00155-5"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10391"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00570140"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002040050336"},{"key":"e_1_2_1_95_2","first-page":"554","article-title":"Metabolic chiral inversion of stiripentol in the rat. II. Influence of route of administration","volume":"22","author":"Cuyue T","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.10240"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.42.1157"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1002\/tcm.1770140303"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2005.07.021"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-022X(02)00123-9"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(01)00231-5"},{"key":"e_1_2_1_102_2","first-page":"216","article-title":"On the racemization of L\u2010noradrenaline bitartrate","volume":"30","author":"El\u2010Nimr AE","year":"1975","journal-title":"Pharmazie"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.38.180"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.49.101"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(02)00016-X"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.20263"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.10180"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530050207"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016245101389"},{"key":"e_1_2_1_110_2","first-page":"853","article-title":"Stereoselective disposition of carprofen, flunoxaprofen and naproxen in rats","volume":"19","author":"Iwakawa S","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_1_111_2","first-page":"767","article-title":"Species\u2010dependent enantioselective glucuronidation of three 2\u2010arylpropionic acids. Naproxen, ibuprofen and benoxaprofen","volume":"15","author":"el Mouelhi M","year":"1987","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.36.1834"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01974986"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826079708013658"},{"key":"e_1_2_1_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(96)01097-7"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(99)00075-8"},{"key":"e_1_2_1_117_2","first-page":"308","article-title":"Rearrangement, racemization and decomposition of peptides in aqueous solution","volume":"4","author":"Sepetov NF","year":"1991","journal-title":"Pept Res"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600811015"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530040404"},{"key":"e_1_2_1_120_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20010"}],"container-title":["Chirality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fchir.20397","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/chir.20397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T07:51:24Z","timestamp":1736927484000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/chir.20397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,28]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1002\/chir.20397"],"URL":"https:\/\/doi.org\/10.1002\/chir.20397","archive":["Portico"],"relation":{},"ISSN":["0899-0042","1520-636X"],"issn-type":[{"value":"0899-0042","type":"print"},{"value":"1520-636X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,28]]}}}